- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Medium dose of BIIL 284 BS tablets
Total 1114 results
-
Shanghai Jiao Tong University School of MedicineYUNNAN BAIYAO GROUP CO.,LTDCompletedAsymptomatic COVID-19China
-
Sinovac Biotech Co., LtdCompleted
-
Actavis Inc.Completed
-
Dr. Reddy's Laboratories (Thailand) LimitedNot yet recruitingHealthy VolunteersThailand
-
Sinovac Research and Development Co., Ltd.Completed
-
Lykos TherapeuticsCompletedPosttraumatic Stress DisorderUnited States
-
Actavis Inc.Completed
-
Universidade Federal de PernambucoCompleted
-
Johnson & Johnson Consumer Inc., McNeil Consumer...CompletedPost-operative Dental PainUnited States
-
Hartford HospitalWithdrawnBeta-CaryophylleneUnited States
-
University of UtahCompletedVenous Thromboembolism | Deep Venous Thrombosis | Pulmonary EmbolusUnited States
-
University of TennesseeWithdrawn
-
Huazhong University of Science and TechnologyWuhan Union Hospital, China; Guangzhou University of Traditional Chinese Medicine and other collaboratorsUnknownFunctional Constipation | Functional DiarrheaChina
-
Boehringer IngelheimEli Lilly and CompanyCompletedHyperglycemia | Diabetes Mellitus, Type 2United States, Brazil, Canada, Czech Republic, Egypt, France, Germany, Guatemala, Korea, Republic of, Lebanon, Malaysia, Mexico, Peru, Philippines, Russian Federation, Serbia, Spain, Taiwan, Thailand, Turkey, United Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
Second Affiliated Hospital, School of Medicine,...National Clinical Research Center, Southern Medical University; Ningbo Yinzhou...Completed
-
Boehringer IngelheimCompleted
-
Mylan Pharmaceuticals IncCompleted
-
National Hospital Organization Okayama Medical...Bayer Yakuhin, Ltd.Recruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Acasti Pharma Inc.Active, not recruitingAtaxia TelangiectasiaCanada
-
TScan Therapeutics, Inc.RecruitingMelanoma | Cervical Cancer | Head and Neck Cancer | HPV-Related Malignancy | Ovarian Cancer | HPV-Related Carcinoma | HPV-Related Cervical Carcinoma | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Non-small Cell Carcinoma | HPV - Anogenital Human Papilloma Virus Infection | HPV-Related Adenocarcinoma | HPV-Related Adenosquamous Carcinoma and other conditionsUnited States
-
Mylan Pharmaceuticals IncCompletedHealthyUnited States
-
Tonix Pharmaceuticals, Inc.Withdrawn
-
CAR-T (Shanghai) Biotechnology Co., Ltd.Unknown
-
Christopher BellAstraZenecaCompletedWeight LossUnited States
-
Actavis Inc.Completed
-
Actavis Inc.Completed
-
VA Office of Research and DevelopmentRecruitingMetastatic Prostate CancerUnited States
-
AstraZenecaRecruiting
-
Mylan Pharmaceuticals IncCompletedHealthyUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Denmark, France, Ireland, Korea, Republic of, Portugal, United Kingdom
-
Tonix Pharmaceuticals, Inc.CompletedPrimary FibromyalgiaUnited States
-
Mylan Pharmaceuticals IncCompleted
-
Actavis Inc.Completed
-
Actavis Inc.Completed
-
Rambam Health Care CampusBoehringer IngelheimUnknownHeart Failure | Diabetes Mellitus | Arrythmia
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited Kingdom
-
Inje UniversityUnknownColonoscopyKorea, Republic of
-
Actavis Inc.Completed
-
Jaeb Center for Health ResearchXeris PharmaceuticalsCompleted
-
Mylan Pharmaceuticals IncCompleted
-
Kartal Kosuyolu Yuksek Ihtisas Education and Research...CompletedPostoperative Residual Curarization | Neuromuscular Blockade | Complication of Anesthesia | Rocuronium | Sugammadex | Neostigmine
-
Bing HanCompletedPure Red Cell Aplasia, AcquiredChina
-
Mylan Pharmaceuticals IncCompleted
-
Boehringer IngelheimCompleted
-
Alexandria UniversityUniversity of AlexandriaCompletedHelicobacter Pylori InfectionEgypt
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Belgium, Canada, France, India, Italy, Korea, Republic of, Malaysia, Netherlands, Spain
-
Marker Therapeutics, Inc.CompletedBreast CancerUnited States